Cloturin
Alternative Names: VUFB 15686Latest Information Update: 14 Apr 2010
Price :
$50 *
At a glance
- Originator VUFB
- Developer Zentiva
- Class Antineoplastics
- Mechanism of Action Hypoxanthine phosphoribosyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 25 Sep 2000 Profile reviewed but no significant changes made